DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice

키워드

참고문헌 (41)

1. Dubey JP, "The history of Toxoplasma gondii--the first 100 years", J Eukaryot Microbiol, 55, pp.467~475 (2008)
2. Montoya JG, "Toxoplasmosis", Lancet, 363, pp.1965~1976 (2004)
3. Cenci-Goga BT, "Toxoplasma in animals, food, and humans: an old parasite of new concern", Foodborne Pathog Dis, 8, pp.751~762 (2011)
4. McLeod R, "Why prevent, diagnose and treat congenital toxoplasmosis?", Mem Inst Oswaldo Cruz, 104, pp.320~344 (2009)
5. Weiss LM, "Toxoplasmosis : a history of clinical observations", Int J Parasitol, 39, pp.895~901 (2009)
6. Andrade GM, "Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy", J Pediatr (Rio J), 86, pp.85~88 (2010)
7. Meng M, "DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB", c mice, 2013, pp.13, 494~
8. Jongert E, "Vaccines against Toxoplasma gondii : challenges and opportunities", Mem Inst Oswaldo Cruz, 104, pp.252~266 (2009)
9. Hiszczyńska-Sawicka E, "DNA vaccines and recombinant antigens in prevention of Toxoplasma gondii infections-current status of the studies", Wiad Parazytol, 55, pp.125~139 (2009)
10. Que X, "Cathepsin Cs are key for the intracellular survival of the protozoan parasite, Toxoplasma gondii", J Biol Chem, 282, pp.4994~5003 (2007)
11. Dou Z, "Cathepsin proteases in Toxoplasma gondii", Adv Exp Med Biol, 712, pp.49~61 (2011)
12. Saade F, "Technologies for enhanced efficacy of DNA vaccines", Expert Rev Vaccines, 11, pp.189~209 (2012)
13. Kakimi K, "Natural killer T cell activation inhibits hepatitis B virus replication in vivo", J Exp Med, 192, pp.921~930 (2000)
14. Kamijuku H, "Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses", Mucosal Immunol, 1, pp.208~218 (2008)
15. Dhodapkar MV, "Harnessing natural killer T(NKT)cells in human myeloma : progress and challenges", Clin Immunol, 140, pp.160~166 (2011)
16. Gonzalez-Aseguinolaza G, "Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines", J Exp Med, 195, pp.617~624 (2002)
17. Lu G, "α-Galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii", BMC Infect Dis, 14, pp.3862~ (2014)
18. Bai Y, "Toxoplasma gondii: bioinformatics analysis, cloning and expression of a novel protein TgIMP1", Exp Parasitol, 132, pp.458~464 (2012)
19. Van Regenmortel MH, "What is a B-cell epitope?", Methods Mol Biol, 524, pp.3~20 (2009)
20. Gao J, "BEST: improved prediction of B-cell epitopes from antigen sequences", PLoS One, 7, pp.e40104~ (2012)
21. Cong H, "Multi-epitope DNA vaccine linked to the A2", B subunit of cholera toxin protect mice against Toxoplasma gondii, 2008, pp.26, 3913~3921
22. Romano P, "Tools and collaborative environments for bioinformatics research", Brief Bioinform, 12, pp.549~561 (2011)
23. Reilly EC, "Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection", PLoS One, 7, pp.e37991~ (2012)
24. Wang Y, "Review on the identification and role of Toxoplasma gondii antigenic epitopes", Parasitol Res, 115, pp.459~468 (2016)
25. Martin DM, "GOtcha: a new method for prediction of protein function assessed by the annotation of seven genomes", BMC Bioinformatics, 5, pp.178~ (2004)
26. Wang Y, "Analyzing and identifying novel B cell epitopes within Toxoplasma gondii GRA4", Parasit Vectors, 7, pp.474~ (2014)
27. Filisetti D, "Immune response to Toxoplasma gondii", Ann Ist Super Sanita, 40, pp.71~80 (2004)
28. El-Kady IM, "T-cell immunity in human chronic toxoplasmosis", J Egypt Soc Parasitol, 41, pp.17~28 (2011)
29. Oldenhove G, "Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection", Immunity, 31, pp.772~786 (2009)
30. Sayles PC, "B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii", Infect Immun, 68, pp.1026~1033 (2000)
31. Kang H, "Decreased resistance of B celldeficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase", J Immunol, 164, pp.2629~2634 (2000)
32. Liu KY, "Biological role of surface Toxoplasma gondii antigen in development of vaccine", World J Gastroenterol, 12, pp.2363~2368 (2006)
33. Zheng B, "The virulence-related rhoptry protein 5(ROP5)of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice", Vaccine, 31, pp.4578~4584 (2013)
34. Gazzinelli RT, "Interleukin 12is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts", Proc Natl Acad Sci U S A, 90, pp.6115~6119 (1993)
35. Machado AV, "Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity", Vaccine, 28, pp.3247~3256 (2010)
36. Gazzinelli RT, "In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-γ", J Immunol, 157, pp.798~805 (1996)
37. Dawson HD, "Localized multigene expression patterns support an evolving Th1", Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum, 2005, pp.73, 1116~1128
38. Desolme B, "Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4gene", Vaccine, 18, pp.2512~2521 (2000)
39. Zhao G, "Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis", Parasit Vectors, 6, pp.175~ (2013)
40. Kitamura H, "The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells", J Exp Med, 189, pp.1121~1128 (1999)
41. Ichikawa T, "α-Galactosylceramide-activated murine NK1.1(+) invariant-NKT cells in the myometrium induce miscarriages in mice", Eur J Immunol, 46, pp.1867~1877 (2016)

관련 논문AI추천